Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.
(Studio: Peter Jennings) Report introduced.
(New York: John McKenzie) FDA (Food and Drug Administration) investigation of the high blood pressure drugs adalat and procardia, known by the generic name nifedipine, featured. [Bowman Gray school of medicine Dr. Kurt FERBERG, New York Hospital Dr. John LARAGH - cite the health risks from nifedipine.] Written statements from drug makers Bayer and Pfizer quoted. [Montefiore-Einstein hospital Dr. Edmund SONNENBLECH, LARAGH - offer differing opinions on the studies on nifedipine.] The overall question of problems with calcium channel blockers, for which there are no conclusive research studies, outlined. [Public Citizen Health Dr. Sidney WOLFE - cites the risks.]
- Jennings, Peter;
- McKenzie, John
Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.
Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:
- You may request a loan of this video by registering on our website and placing an order.
- You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
- If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.
If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.